7.1799
price up icon2.57%   0.1799
 
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
24.85%
5.814
7.737 - - -
Operating Income/Loss
37.21%
-10.33
-16.46 -14.27 -20.70 -17.38
Income/Loss From Continuing Operations Before Tax
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Income/Loss From Continuing Operations After Tax
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Net Income/Loss
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.90%
3.1689
62.11 0.4845 61.76 61.68
Diluted Average Shares
94.90%
3.1689
62.11 0.4845 61.76 61.68
Basic Earnings Per Share
1,084%
-2.96
-0.25 -0.20 -0.31 -0.26
Diluted Earnings Per Share
1,084%
-2.96
-0.25 -0.20 -0.31 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):